Joshi, S., Chang, S. S., Dickstein, R. J., Jayram, G., Shore, N. D., Liu, J., Lotan, Y., Satkunasivam, R., Schuckman, A. K., Steinberg, G. D., Taylor, J. R., Linback, T., Pruthi, R., Sullivan, J. C., Tosone, C., Kamat, A. M. (2025). A phase 1/2 study of detalimogene voraplasmid (EG-70) intravesical monotherapy for patients with high-risk non-muscle invasive bladder cancer (NMIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps886